Compensatory combination of mTOR and TrxR inhibitors to cause oxidative stress and regression of tumors

Background: Cancer is a leading cause of death worldwide. Extensive research over decades has led to the development of therapies that inhibit oncogenic signaling pathways. The mammalian target of rapamycin (mTOR) signaling pathway plays an important role in the development of many cancers. Several...

Descripción completa

Detalles Bibliográficos
Autores principales: Xia, Yiqun, Chen, Jundixia, Yu, Yun, Wu, Fengjiao, Shen, Xin, Qiu, Chenyu, Zhang, Tingting, Hong, Lin, Zheng, Peisen, Shao, Rongrong, Xu, Chenxin, Wu, Fang, Chen, Wei, Xie, Congying, Cui, Ri, Zou, Peng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7977446/
https://www.ncbi.nlm.nih.gov/pubmed/33754064
http://dx.doi.org/10.7150/thno.52077

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7977446/
https://www.ncbi.nlm.nih.gov/pubmed/33754064
http://dx.doi.org/10.7150/thno.52077

Ejemplares similares